https://hotcopper.com.au/posts/56782319/single
"Furthermore, by the 27th of February, the results of 42 clinical trials, including
approximately 15,000 patients (both registered and unregistered studies) have been
subjected to a meta-analysis after exclusion of biasing factors. It was found that 83%
showed improvements with early treatment, 51% improved during late-stage
treatment, and there was an 89% prevention of onset rate noted. This confirms the
usefulness of ivermectin. Since it is a meta-analysis based on 42 test results, it is
estimated that the probability of this comprehensive judgment being a mistake is as
low as 1 in 4 trillion. In addition, two separate meta-analyses also showed the
46 ( 46 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 74―1 Mar. 2021
usefulness of ivermectin and their conclusions were presented to the WHO and the
US FDA with a request for an expansion of the indication of ivermectin in the
treatment of COVID-19" .....
A very good and long read to the background on IVM. Some discussion on in vitro experiment which killed most of the cv19 with 48 hrs, is suggested by nay sayers that same concentration, if to in human blood concentrations would be too high a dose, but is countered by the fact that much smaller doses are demonstrated in the trials above, to actually work well. Hence i would infer, that the levels in vitro, were too high to begin with / or that other modes of action are working in tandem with a lower dosage rate in trials. In essence, a large dose in vitro wiped out cv19 in 48 hrs, and a lower dose is proving quite effective in trials. Either way, IVM is kicking ass.
- Forums
- Science & Medicine
- Background story to CV19 / HCQ and IVM treatments
https://hotcopper.com.au/posts/56782319/single"Furthermore, by...
- There are more pages in this discussion • 4,249 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online